Santa Monica-based healthcare startup Heal announced a $100 million investment and partnership with health insurance provider Humana, a move that will vastly extend the reach of their on-demand doctor service.
Humana hopes to use Heal's applications for its Medicare Advantage program, providing more in-home care to seniors. It will also bring the service to major metro areas including Chicago, Houston and Charlotte.
Heal's CEO Nick Desai, who is fond of saying that the traditional doctor's office is dead, said it will help his company grow nationally and develop more predictive tools to guide doctors with care.
"You want a headline?" Desai joked after making the joint announcement, "Heal wins $100 million to bring concierge care to all Americans."
"We want to expand, so we go nationwide," Desai said. "We like to think the real winners in this is the millions of Americans who get health care this way. "
Heal CEO Nick Desai and Chief Medical Officer Renee Dua are married.
Heal boasts 200,000 home visits since it launched five years ago and expects to see 250% revenue growth between this and next year. Started by Desai and his wife, a medical doctor, after waiting seven hours for their then one year old to see an emergency doctor, the company has been on fast growth trajectory as traditional insurers look to startups for new ways to deliver care. He wouldn't provide revenue, but said it was in the tens of millions of dollars.
Humana, with about 17 million members, will use the services for its government-subsidized Medicare Advantage program as it seeks to build on its 34% penetration — as of 2019 — in the market.
"Our goal is to make the healthcare experience easier, more personalized and caring for the people we serve," said Susan Diamond, Humana's segment president for home business, who is joining Heal's board. "We continue to see high levels of customer satisfaction and improved health outcomes when care is delivered in the home,"
Humana said the partnership will help it fulfill its mission of addressing the needs of the whole person by giving doctors greater insight into health with at-home visits. There, doctors can see the social factors that may be impacting patients' health, such as a steep staircase or exposure to environmental hazards like pollution.
Most doctors see 8 to 10 patients, much fewer than regular physicians who often see dozens of patients in a day. The model, he said, brings down emergency room visits and elevates preventive care, making it appealing to insurers.
It's also a throwback.
"In 1970, 50% of all primary health care in America was delivered by house calls. Today it's less than 10%," he said. "That went away with insurance and fee-for-service care, Medicare. We are bringing it back."
But unlike the 70s, Heal monitors blood pressure, blood sugar and other vitals remotely using cloud connected devices to provide insight into patient care.
Last fall, the company, which operates fully in seven states and Washington D.C., bought Doctors on Call in New York City. That allowed it to make an entrance into the nation's largest city that was also, at one time, its largest coronavirus hotspot.
To deal with the pandemic, Heal protocol was to schedule an initial telemedicine call before scheduling a house visit to make sure their doctors weren't going to be exposed to the coronavirus.
"You know today, you don't want to go to the doctor's office because of COVID, but tomorrow it will be something else," he said. "You will never want to go to the doctor's office. Why would ever go to the doctor if the doctor comes to your house?"
Heal investors include former Qualcomm CEO and Executive Chairman Paul Jacobs, who is the company's chairman of the board, IRA Capital, Fidelity ContraFund, Jim Breyer, singer Lionel Richie and former Florida Governor Jeb Bush.
**This story has been update to include an interview with Heal's CEO.
- Watch: Three Health and Wellness Leaders Look at the Future of the ... ›
- Investors and Health Tech on the Front Lines of the Pandemic - dot.LA ›
Culver City-based Airvet's mission to connect more pets with vets is getting a boost.
The company announced Friday they have raised $14 million in a Series A round to expand their telemedicine and telehealth veterinary network.
CEO Brandon Werber said he's seen the number of users and doctors on its platform surge during the pandemic, as homebound pet owners scrambled to find pet care online. The company — which was launched in 2018 — now has a network of 2,600 veterinarians across 43 states, according to Werber.
Photo courtesy of Airvet
- airvet - dot.LA ›
- Airvet Raises $14M to Provide Telehealth to Pets - dot.LA ›
- Is Telemedicine At a Tipping Point? L.A. Doctors Hope So - dot.LA ›
- Cuddly Raises $4M to Help Animal Shelters Collect Donations - dot.LA ›
The spread of the novel coronavirus has sped the adoption of telemedicine in the United States, eliminating barriers like insurance reimbursements. It's also shone a light on the need for faster vaccines and a need for greater investment in public health, experts said on a dot.LA virtual panel Tuesday that looked at how investors are responding to COVID-19.
A move to telemedicine "was a long time coming," said Dr. Jeffrey Klausner, a professor of medicine in the division of infectious diseases in the David Geffen School of Medicine at UCLA. "A lot of doctors and institutions weren't comfortable with that" but now those concerns have been "blown out of the water." Since the pandemic erupted, two-thirds of UCLA medical visits have been done using telehealth.
Dr. Jeffrey Klausner, MD, MPH, is a Professor of Medicine in the Division of Infectious Diseases in the David Geffen School of Medicine.
Jeffrey Klausner, MD, MPH, is a Professor of Medicine in the Division of Infectious Diseases in the David Geffen School of Medicine and Adjunct Professor of Epidemiology in the Fielding School of Public Health.<p>Dr. Klausner earned his Medical Degree from Cornell University Medical College with Honors in Research. He completed his Residency in Internal Medicine at the New York University—Bellevue Hospital Center. Dr. Klausner earned his Master's in Public Health with a focus on International Health and Epidemiology at the Harvard School of Public Health. After that training, Dr. Klausner was an Epidemic Intelligence Service Officer at the Centers for Disease Prevention and Control. Dr. Klausner completed his Fellowship in Infectious Diseases at the University of Washington, Seattle.</p>
Jay Goss is General Partner at Wavemaker Three-Sixty Health
Jay Goss, General Partner @ Wavemaker Three-Sixty Health<p><span id="selection-marker-1" class="redactor-selection-marker" data-verified="redactor"></span>Jay is a General Partner at Wavemaker Three-Sixty Health. Wavemaker Three-Sixty Health is Southern California's leading Seed-stage healthcare-focused venture capital fund. The fund's investment thesis is that after 40+ years, healthcare is transitioning away from fee-for-service to value-based payments, and with that comes a massive amount of disruption. There will be no shortage of clinical operations and business challenges to solve in the coming decade, and entrepreneurs are already coming out of the woodwork to solve these problems. Moreover, countless business models are now for the first time commercially viable because the healthcare industry is embracing value-based payments. The fund counts among its investors 50+ healthcare senior executives, eager and extremely able to add value to the early stage companies in which the fund invests. Prior to launching Wavemaker Three-Sixty Health, Jay operated dozens of early stage companies all over Southern California, and advised dozens more.<span id="selection-marker-2" class="redactor-selection-marker" data-verified="redactor"></span> </p>
Llewellyn Cox is a general partner at MarsBio
Llewellyn Cox, General Partner at MarsBio<p>Llewellyn is an entrepreneur from Gillingham, Kent, England. He founded LabLaunch, the leading biotechnology incubator network in Southern California, and BioBuilt, a firm that assists early-stage companies in building lab space.Llewellyn received a Ph.D. in Molecular and Cell Biology at Cardiff University, before moving to New York City to perform postdoc research in neuroscience at Weill Cornell Medical College. Llewellyn is an adjunct professor at Keck Medicine of USC where he teaches translational biology and science communications.</p>
Rachel Uranga, is a reporter at dot.LA.
Rachel Uranga, Reporter @dot.LA<p>Rachel covers the intersection of business, technology and culture. She is a former Mexico-based market correspondent at Reuters and has worked for several Southern California news outlets, including the Los Angeles Business Journal and the Los Angeles Daily News. She has covered everything from IPOs to immigration. Uranga is a graduate of the Columbia School of Journalism and California State University Northridge. A Los Angeles native, she lives with her husband, son and their felines. </p>
- Investors Are Still Writing Checks During the Coronavirus Pandemic ... ›
- venture-capital - dot.LA ›
- Here Are the Investors Still Writing Checks During the Coronavirus ... ›
- Leading VC Warns Coronavirus is a 'Black Swan' Event - dot.LA ›
- Coronavirus Stokes Investor Fears – From Venture Capital to Wall ... ›
- L.A. Venture Capital Firm MarsBio Scrambles to Secure Cash ... ›
- Coronavirus Updates: Virgin Orbit Gets OK on Ventilators, Curative Signs Pact With Air Force - dot.LA ›
- Watch Three Los Angeles Health Startups Pitch Investors - dot.LA ›
- Can LA County's New Fund Get Local Biotech Startups to Stick Around? - dot.LA ›
- Heal Get's $100M in Humana Deal to Extend Telehealth - dot.LA ›
- Making At-Home Healthcare As Easy as Ordering Pizza - dot.LA ›
- The LA Dodgers Get Into Food Delivery - dot.LA ›